Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
The Latest Breaking News on After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Get all your
news in one place.
news in one place.
100’s of premium titles.
One news app.
One news app.
Get all your
news in one place.
news in one place.
100’s of premium titles.
One news app.
One news app.
People
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Organisations
NHS
17,710 stories
FDA
4,118 stories
Salon
1,468 stories
NHS England
1,080 stories
NICE
965 stories
Eli Lilly
523 stories
CMS
271 stories
Biogen
258 stories
UCL
256 stories
Lilly
238 stories
KFF
208 stories
Alzheimer Society
205 stories
the Food and Drug Administration
96 stories
Alzheimer Research UK
93 stories
Eisai
90 stories
Biogen Inc
79 stories
Eli Lilly and Company
42 stories
JAMA
28 stories
the Alzheimer Association
25 stories
Leqembi
24 stories
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Topics